Skip to content

Prevention of Stroke and Systemic Embolism in Adult Patients with Non-valvular Atrial Fibrillation with One or More Risk Factors

A selection of medicines used for Prevention of Stroke and Systemic Embolism in Adult Patients with Non-valvular Atrial Fibrillation with One or More Risk Factors is listed below, including Rivaroxaban. Products containing Rivaroxaban feature in this group. Prices and product details are shown for comparison.

Xarelto

Rivaroxaban

15mg

Directly inhibits factor Xa to interrupt both intrinsic and extrinsic coagulation pathways, reducing thrombin generation and preventing formation and extension of blood clots.

From$2.98/ tabletView

Review product labelling and speak with a healthcare professional before treatment decisions.